noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Georgia Department of Transportation

Interstate Closure Advisory for the 16@95 Improvement Projects
Georgia Department of Transportation

Fayette Co SR 54 traffic interruptions to be expected in Peachtree City
Georgia Department of Transportation

🚧I-16/I-75 Interchange Improvement Project Updates: March 6-13, 2026

Healthcare

Barbara Ann Karmanos Cancer Institute

01/22/2026 | Press release | Archived content

IN THE NEWS – Decentralized Trials 101: How to Decide if a DCT Model Fits Your Study and Keep Data Quality High

January 22, 2026

Cure

With advances in technology, decentralized trials are becoming a more viable option for some clinical trials. Jeffrey Zonder, M.D., hematologist and leader of the Multiple Myeloma and Amyloidosis Multidisciplinary Team, led the first decentralized trial at Karmanos. He shared how to determine if elements of some clinical studies can be safely moved to a virtual format.

Read the article here.

Barbara Ann Karmanos Cancer Institute published this content on January 22, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on February 15, 2026 at 13:05 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back

View original format